BioReference Health, LLC recalls The 4Kscore Test
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Mathematical modeling of the 4Kscore with and without DRE information was recently performed on over 3,000 specimens. DRE information is a required component of The 4Kscore Test.
- Products
-
- The 4Kscore Test
- Company
- BioReference Health, LLC
- Where it was sold
-
US Nationwide distribution.
Nationwide
- Barcodes
00850038860004- Units affected
- 1 system (3,196 tests)
- About this recall
- The 4Kscore Test, an in vitro serum or plasma test that combines the results of four immunoassays (Roche Elecsys total PSA (prostate specific antigen), Roche Elecsys free PSA, intact PSA, and human kallikrein 2) into a single numerical score that also incorporates the following information: a patient s age, previous biopsy, and digital rectal exam (DRE).